SBH Sciences is an innovative preclinical contract research organization (CRO) dedicated to providing the scientific community with unique discovery services, and additionally high-quality research products such as cytokines, enzymes and monoclonal antibodies.
Analysis of over 150 Biomarkers with expanded multiplex analysis capabilities, 370 human cancer cell lines on hand, 300 cell-based bioassays to measure biological activity of cytokines, commercial production of 31 recombinant cytokines, 8 recombinant Glycosyltransferase enzymes, 33 monoclonal antibodies, and the development of 30 ELISA kits. SBH Sciences is the world leader in cell-based assays to measure biological activity of cytokines and growth factors, and has provided services to over 250 biotechnology companies across the globe during our 23 years of business.
SBH plays a substantial role in supporting the development of 7 NCEs including 1 approved drug. By offering our clients superior products and services, we guarantee on time delivery. SBH Sciences supports start-up companies, entrepreneur scientists, and the biotechnology industry with our experience and expertise to help shorten your time-lines and reduce costs. Moreover, SBH Sciences is always looking for collaboration and partnership deals and is willing to consider a risk-shared business arrangement.
SBH Sciences is a Pre-Clinical Contract Research Organization offering:
- Protein Production Services
- Biomarker Analysis
- Cell-Based Assays
- Cell and Gene Therapy